Charles Schwab’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,486
| Closed | -$5.5K | – | 3701 |
|
|
2023
Q1 | $5.5K | Hold |
1,486
| – | – | ﹤0.01% | 3546 |
|
|
2022
Q4 | $5.65K | Hold |
1,486
| – | – | ﹤0.01% | 3543 |
|
|
2022
Q3 | $12K | Hold |
1,486
| – | – | ﹤0.01% | 3504 |
|
|
2022
Q2 | $32K | Buy |
+1,486
| New | +$32K | ﹤0.01% | 3460 |
|
|
2021
Q3 | – | Sell |
-786
| Closed | -$76K | – | 3553 |
|
|
2021
Q2 | $76K | Sell |
786
-1,272
| -62% | -$123K | ﹤0.01% | 3315 |
|
|
2021
Q1 | $305K | Hold |
2,058
| – | – | ﹤0.01% | 3235 |
|
|
2020
Q4 | $288K | Hold |
2,058
| – | – | ﹤0.01% | 3172 |
|
|
2020
Q3 | $313K | Sell |
2,058
-116
| -5% | -$17.6K | ﹤0.01% | 3014 |
|
|
2020
Q2 | $382K | Buy |
+2,174
| New | +$382K | ﹤0.01% | 2941 |
|
|
2015
Q2 | – | Sell |
-77
| Closed | -$79K | – | 3133 |
|
|
2015
Q1 | $79K | Hold |
77
| – | – | ﹤0.01% | 3048 |
|
|
2014
Q4 | $258K | Hold |
77
| – | – | ﹤0.01% | 2906 |
|
|
2014
Q3 | $225K | Hold |
77
| – | – | ﹤0.01% | 2908 |
|
|
2014
Q2 | $294K | Buy |
+77
| New | +$294K | ﹤0.01% | 2868 |
|